INHBA+ cancer-associated fibroblasts drive SMAD2-dependent PD-L1 expression and promote regulatory T-cell differentiation in advanced ovarian cancer, nominating INHBA protein/RNA and CAF-PD-L1 as tissue surrogates of TGF-β superfamily–linked immune suppression (72–74). The gene discussed is SMAD2; the disease is ovarian carcinoma.